📣 Paris PSVD Meeting, Session 1 on Dec. 4 Join us tomorrow as we deep dive into pathophysiology and conditions associated with Porto-Sinusoidal Vascular Disease. Topics include: ✅ Prognosis and treatment impact ✅ Genetics and PSVD ✅ Pathophysiology: is PSVD an immune, a

📣 Join us in two weeks! Don’t miss “Resmetirom and Semaglutide for MASH in 2025: Updated Recommendations from AASLD Guidance” — a live webinar discussing the latest updates in MASLD/MASH management, including current and emerging therapies. 📅 Tuesday, December 16, 2025 🕛

Grow faster on the world's largest group chat.

In conjunction with ALEH, join AASLD’s Dr. Juan Pablo Arab and leading experts as they discuss the latest advancements in ALD and MetALD. Don’t miss this exciting collaboration — screening strategies, treatment approaches, current controversies, and updates on early liver

Organized by Dr. Juan Pablo Arab on behalf of AASLD and ALEH, distinguished experts will discuss the latest advances in #ALD and #MetALD in their upcoming webinar with an open Q&A panel. A must-attend session for hepatology professionals with simultaneous interpretation available

📣 Paris PSVD Meeting, Session 1 on Dec. 4 Join us as we deep dive into pathophysiology and conditions associated with Porto-Sinusoidal Vascular Disease. Topics include: ✅ Prognosis and treatment impact ✅ Genetics and PSVD ✅ Pathophysiology: is PSVD an immune, a vascular,

What an inspiring moment at the #TLM25 Women's Networking Luncheon where all seven #AASLD female presidents stood together. Attendees shared how meaningful it was to see this legacy of leadership in one room.

⏪ Monday Rewind ⏪ Monday was all about making connections that matter. From hallway conversations to new collaborations, #TLM25 continued to bring the liver community together — here’s to a strong finish on the final day! 🤝

🏆 Congratulations to the AASLD Pickleball Tournament Winners! 🏓 We are thrilled to celebrate another amazing year of competition at #TLM25! Beginner Winners: 🥇 Gold Medal: Thomas Cotter & Naim Alkhouri 🥈 Silver Medal: Sagnik Biswas & Sarthak Saxena Intermediate Winners:

⏪ Sunday Rewind ⏪ What a way to wrap up the weekend! ☀️ We are still smiling from all the fun at The Park @ TLM! From meet-ups to pickleball and golf, it was the perfect way to close out the weekend with connection and energy.

⏪ Saturday Rewind ⏪ From passionate Academic Debates to packed sessions and new connections — Day 2 of #TLM25 brought the heat! 🔥

⏪ Friday Rewind ⏪ Day 1 of #TLM25 brought the IMPACT — powerful sessions, new connections, and a night of AASLD and @AASLDFoundation Awards honoring those shaping the future of liver care. 💥 The IMPACT continues today as we head into day 2!

Celebrating excellence in hepatology! 🌟 We proudly recognized this year’s awardees and honorees at the #TLM25 Awards & Honors Gala. Join us in congratulating this incredible group of 2025 AASLD Distinguished Awardees! 👏👏

🚨 Now Online in @HEP_Journal: Updated #AASLD Practice Guidance on Semaglutide therapy for MASH. #hepatology #liverdisease #MASLD #TLM25 https://t.co/es1CNIiEvj

@HEP_Journal Explore what’s new in prevention, surveillance, and therapy. Join us at #TLM25 for the What’s New in 2025 Practice Guidelines session on Sun., Nov. 9 at 5 PM & Science in the Park: AASLD Practice Guideline on Treatment of Chronic Hepatitis B on Mon., Nov. 10 at 9:45 AM. Learn

Ready to take the next step in your hepatology career? The AASLD Career Center is your trusted destination for opportunities across clinical practice, research, and academia – focused on liver disease. Here’s what you’ll find: ✔️ Curated job listings from leading institutions

NEW & now online in @HEP_Journal: #AASLD & #IDSA Practice Guideline on the Treatment of Chronic #HepatitisB. Read the NEW Guideline in HEPATOLOGY here: https://t.co/vqQcFe2ATn Dig deeper with more resources to read, learn, and implement: https://t.co/WGj7JHw5Li

❗ The chance to submit a #HepMadness bracket ends today at 5 p.m. ET! Submit your bracket now to guess which liver article from @LtxJournal and @HepCommJournal will stand on top. @LiverFellow https://t.co/Xaeb2dJ9HH

Even during a #governmentshutdown, #LiverHealth #advocacy doesn’t stop. #AASLD continues to engage policymakers to protect liver science and promote key #publichealth priorities. Your voice matters: https://t.co/P2jnz4slsY

Did you know?📈 All #AASLD journals are in Quartile 1 in Gastroenterology & #Hepatology for 2024: HEPATOLOGY: 16.8 Hepatology Comm: 4.6 Liver Transplantation: 4.2 Our journals’ influence continues to grow. Read the latest groundbreaking #research: https://t.co/SiBOD7pgar

⚡ Join the #HepMadness! Exceptional liver articles from our very own @LtxJournal and @HepCommJournal are going head-to-head — tournament style. Submit your bracket to compete by Friday, Oct. 31, at 5 p.m. ET, and see who will come out on top. @LiverFellow https://t.co/Xaeb2dJ9HH